Literature DB >> 23992104

High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China.

Y Cao1, V Minhas, X Tan, J Huang, B Wang, M Zhu, Y Gao, T Zhao, L Yang, C Wood.   

Abstract

In China, KSHV seroprevalence varies considerably among different regions and ethnicities. But in Xinjiang province, located in the northwestern China, there is a very high seroprevalence of KSHV in adults of Kazak and Ughur ethnicities. However, KSHV prevalence in children and the risk factors associated with the acquisition of infection are currently not known. The aim of this study was to investigate the prevalence of KSHV infection and identify associated socioeconomic or behavioural risk factors and the humoral immune response among children in this population. This is a cross-sectional study (N = 178) to screen children and their caregivers from Xinjiang for total KSHV antibodies, KSHV neutralizing antibodies and HIV infection. Structured questionnaires were utilized to investigate risk factors associated with KSHV prevalence. KSHV seroprevalence in children and caregivers in Xinjiang was 48.3% and 64.7%, respectively. Neutralizing antibody was detected in most seropositive caregivers (93.8%) but was detected in only 5.8% of the infected children. A significant association was observed between child KSHV seroprevalence and sharing of food among family members. These results suggest that similar to other endemic areas in Africa, KSHV infection in the minority populations of Xinjiang is likely to be occurring during early childhood, probably via horizontal transmission through saliva, and results in high seroprevalence in the adult population.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  China; Kaposi's sarcoma-associated herpesvirus; Xinjiang; seroprevalence

Mesh:

Substances:

Year:  2013        PMID: 23992104      PMCID: PMC3868646          DOI: 10.1111/1469-0691.12340

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  30 in total

1.  HHV-8 seroprevalence in blood donors and HIV-positive individuals in Shandong area, China.

Authors:  Qi Mei; Zhao Wei Ming; Yu Xiu Ping; Jia Ji Hui; Zhou Ya Bin; Wang Hong; Liu Juan; Cheng Yi Zhe; Tang Wei; Yu Han
Journal:  J Infect       Date:  2006-12-08       Impact factor: 6.072

2.  Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan.

Authors:  T Fujii; H Taguchi; H Katano; S Mori; T Nakamura; N Nojiri; K Nakajima; K Tadokoro; T Juji; A Iwamoto
Journal:  J Med Virol       Date:  1999-02       Impact factor: 2.327

3.  Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.

Authors:  Fangping He; Xing Wang; Bin He; Zongdi Feng; Xiaomei Lu; Yaoxin Zhang; Shujun Zhao; Renyong Lin; Yan Hui; Yongxing Bao; Zhaoxia Zhang; Hao Wen
Journal:  J Med Virol       Date:  2007-02       Impact factor: 2.327

4.  Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population.

Authors:  Babatyi I Malope; Ruth M Pfeiffer; Georgina Mbisa; Lara Stein; Edith M Ratshikhopha; Dianne L O'Connell; Freddy Sitas; Patrick MacPhail; Denise Whitby
Journal:  J Acquir Immune Defic Syndr       Date:  2007-03-01       Impact factor: 3.731

5.  HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China.

Authors:  Yuanzhi Zhang; Hua Shan; Jennifer Trizzino; Yuhua Ruan; Geetha Beauchamp; Benoît Mâsse; Jun Ma; Baoling Rui; Jun Wang; Minsheng Liu; Yunxia Wang; Yixin He; Katharine Poundstone; Yan Jiang; J Brooks Jackson; Yiming Shao
Journal:  Int J Infect Dis       Date:  2007-02-22       Impact factor: 3.623

6.  Sexual transmission and the natural history of human herpesvirus 8 infection.

Authors:  J N Martin; D E Ganem; D H Osmond; K A Page-Shafer; D Macrae; D H Kedes
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

7.  Participatory communication and HIV/AIDS prevention in a Chinese marginalized (MSM) population.

Authors:  M Yun Gao; S Wang
Journal:  AIDS Care       Date:  2007-07

8.  Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.

Authors:  Eric A Engels; Jonnae O Atkinson; Barry I Graubard; Geraldine M McQuillan; Christine Gamache; Georgina Mbisa; Silvia Cohn; Denise Whitby; James J Goedert
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

9.  Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area.

Authors:  Veenu Minhas; Kay L Crabtree; Ann Chao; Tendai J M'soka; Chipepo Kankasa; Marc Bulterys; Charles D Mitchell; Charles Wood
Journal:  Am J Epidemiol       Date:  2008-05-30       Impact factor: 4.897

10.  Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.

Authors:  M Melbye; P M Cook; H Hjalgrim; K Begtrup; G R Simpson; R J Biggar; P Ebbesen; T F Schulz
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

View more
  3 in total

1.  SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus.

Authors:  Jungang Chen; Lu Dai; Lindsey Barrett; Jennifer James; Karlie Plaisance-Bonstaff; Steven R Post; Zhiqiang Qin
Journal:  Commun Biol       Date:  2021-06-03

Review 2.  Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  Veenu Minhas; Charles Wood
Journal:  Viruses       Date:  2014-11-04       Impact factor: 5.048

3.  Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.

Authors:  Salum J Lidenge; Andrew V Kossenkov; For Yue Tso; Jayamanna Wickramasinghe; Sara R Privatt; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Paul M Lieberman; John T West; Charles Wood
Journal:  PLoS Pathog       Date:  2020-07-24       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.